Vendor, Seattle, WA
Primary Bioscience, Inc.
UEI L3NSPJDTDD28, CAGE 20RD3
1 award and $939,084 obligated between September 23, 2026 and September 23, 2026, 100% under full and open competition, against 2.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $939,084 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 1 |
| Small Business Set Aside - Total | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 140D0426C0111Definitive Contract, September 23, 2026, Full and Open Competition After Exclusion of Sources, 2 offers | Ibc Acq SVCS DirectorateDepartmental Offices | STTR Phase II - Development of an Ultra-Low Concentration Biosensor for Use in Protein SequencingNAICS 541714, PSC AC15 | $939,084 |
- Places of performance
- Washington
- Product and service codes
- AC15 National Defense R&D Svcs; Department Of Defense - Military; R&D Facilities & Maj Equip
- Transactions
- 1 across 1 awards